NAC in Schizophrenia: Pie in the Sky or Groundbreaking Solution?

<p>Are we missing a vital piece in the schizophrenia treatment puzzle? In this episode, we explore the intriguing and controversial role of N-acetylcysteine (NAC) in schizophrenia. We dive deep into the evidence, the theories, and the ongoing debates about this seemingly simple over-the-counter supplement. Could NAC be the key to unlocking better outcomes for those with schizophrenia, or is it just another dead end?</p> <p>Faculty: Jim Phelps, M.D.<br /> Host: Richard Seeber, M.D.</p> <ul> <li style="font-weight: bold;"><a href= "https://psychopharmacologyinstitute.com/cme-program?section=pricing&utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC249" target="_blank" rel="noopener"><strong>Learn more about our membership here</strong></a></li> <li style="font-weight: bold;"><a href= "https://psychopharmacologyinstitute.com/publication/quick-take-vol-47-2705?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC249" target="_blank" rel="noopener"><strong>Earn 0.5 CMEs: Quick Take Vol. 47</strong></a></li> <li style="font-weight: bold;"><a href= "https://psychopharmacologyinstitute.com/section/antipsychotic-augmentation-with-n-acetylcysteine-for-patients-with-schizophrenia-2705-5387?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC249" target="_blank" rel="noopener"><strong>Antipsychotic Augmentation With N-Acetylcysteine for Patients With Schizophrenia</strong></a></li> </ul>